SEC Form 4 · accession 0001481485-26-000008
TELA Bio, Inc. · TELA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Heather C Getz
Officer — Chief Executive Officer · Director
Period of report
Aug 17, 2026
Accepted (ET)
Aug 19, 2026 · 4:10 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001561921
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 17, 2026 | P | 12,500 | $0.6649 | A | 532,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.6504 to $0.6749. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.